Add to Calendar
06/10/2026 05:00:00 PM06/10/2026 07:00:00 PMAmerica/PhoenixVirtual FAMEThe Arizona Bleeding Disorders and Star Therapeutics is teaming up for a Virtual FAME Event on Wednesday, June 10th. Star Therapeutics’ is investigating a once-monthly subcutaneous prophylactic treatment for VWD called VGA039. If you or someone in your family has any type of VWD, please join us for an engaging session as Dr. Laura Guido shares how VGA039 works, its clinical development path, and early trial results. Dr. Guido will also discuss VIVID Clinical Trials and how to explore eligibility and participate.
Laura Guido PharmD, MBA, BCPS, Executive Director, Medical Affairs at Star Therapeutics: Dr. Guido is a clinical pharmacist and leads Medical Affairs for VGA039 at Star Therapeutics. Previously, she supported clinical development for hemophilia A gene therapy trials at BioMarin and spent numerous years in anticoagulation at Boehringer Ingelheim. Prior to joining industry, Dr. Guido was a clinical pharmacist.
Zoom Virtual Event
About This Event
The Arizona Bleeding Disorders and Star Therapeutics is teaming up for a Virtual FAME Event on Wednesday, June 10th. Star Therapeutics’ is investigating a once-monthly subcutaneous prophylactic treatment for VWD called VGA039. If you or someone in your family has any type of VWD, please join us for an engaging session as Dr. Laura Guido shares how VGA039 works, its clinical development path, and early trial results. Dr. Guido will also discuss VIVID Clinical Trials and how to explore eligibility and participate.
Laura Guido PharmD, MBA, BCPS, Executive Director, Medical Affairs at Star Therapeutics: Dr. Guido is a clinical pharmacist and leads Medical Affairs for VGA039 at Star Therapeutics. Previously, she supported clinical development for hemophilia A gene therapy trials at BioMarin and spent numerous years in anticoagulation at Boehringer Ingelheim. Prior to joining industry, Dr. Guido was a clinical pharmacist.
About This Event
The Arizona Bleeding Disorders and Star Therapeutics is teaming up for a Virtual FAME Event on Wednesday, June 10th. Star Therapeutics’ is investigating a once-monthly subcutaneous prophylactic treatment for VWD called VGA039. If you or someone in your family has any type of VWD, please join us for an engaging session as Dr. Laura Guido shares how VGA039 works, its clinical development path, and early trial results. Dr. Guido will also discuss VIVID Clinical Trials and how to explore eligibility and participate.
Laura Guido PharmD, MBA, BCPS, Executive Director, Medical Affairs at Star Therapeutics: Dr. Guido is a clinical pharmacist and leads Medical Affairs for VGA039 at Star Therapeutics. Previously, she supported clinical development for hemophilia A gene therapy trials at BioMarin and spent numerous years in anticoagulation at Boehringer Ingelheim. Prior to joining industry, Dr. Guido was a clinical pharmacist.
Location
Zoom Virtual Event
Arizona
United States
Date & Time
Wednesday, 06/10/2026
5:00pm MST
-
7:00pm MST
Add to Calendar
06/10/2026 05:00:00 PM06/10/2026 07:00:00 PMAmerica/PhoenixVirtual FAMEThe Arizona Bleeding Disorders and Star Therapeutics is teaming up for a Virtual FAME Event on Wednesday, June 10th. Star Therapeutics’ is investigating a once-monthly subcutaneous prophylactic treatment for VWD called VGA039. If you or someone in your family has any type of VWD, please join us for an engaging session as Dr. Laura Guido shares how VGA039 works, its clinical development path, and early trial results. Dr. Guido will also discuss VIVID Clinical Trials and how to explore eligibility and participate.
Laura Guido PharmD, MBA, BCPS, Executive Director, Medical Affairs at Star Therapeutics: Dr. Guido is a clinical pharmacist and leads Medical Affairs for VGA039 at Star Therapeutics. Previously, she supported clinical development for hemophilia A gene therapy trials at BioMarin and spent numerous years in anticoagulation at Boehringer Ingelheim. Prior to joining industry, Dr. Guido was a clinical pharmacist.
Zoom Virtual Event
